Provider 1205832268
NPI: 1205832268Share
Active Billing Period:2018-01→2024-10(82 months)
Extreme procedure concentration — 100% of $9.7M billed through just 2 codes
Total Paid
$9.7M
$9,682,198
Total Claims
2,268
Beneficiaries
1,822
1.2 claims/patient
Avg Cost/Claim
$4K
Monthly Spending Trend
Yearly Spending
2018
$1.5M
+12%
2019
$1.7M
-9%
2020
$1.6M
-14%
2021
$1.4M
-28%
2022
$977K
+32%
2023
$1.3M
-6%
2024
$1.2M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 2 distinct procedure codes. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile